159 related articles for article (PubMed ID: 37994593)
1. Patterns of major cutaneous surgeries and reconstructions in patients with cutaneous squamous cell carcinoma in the USA.
Chen CI; Jalbert JJ; Wu N; Ruiz ES
Future Oncol; 2024 Apr; 20(11):691-701. PubMed ID: 37994593
[TBL] [Abstract][Full Text] [Related]
2. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of drugs associated with the development of cutaneous squamous cell carcinoma reported by patients on the FDA's adverse events reporting system.
Jean-Pierre P; Nouri K
Arch Dermatol Res; 2024 May; 316(6):250. PubMed ID: 38795220
[TBL] [Abstract][Full Text] [Related]
4. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
5. Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma.
McLean LS; Lim AM; Bressel M; Thai AA; Rischin D
Drugs Aging; 2024 Mar; 41(3):271-281. PubMed ID: 38446342
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma.
Aboul-Fettouh N; Morse D; Patel J; Migden MR
Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021169S. PubMed ID: 34877077
[TBL] [Abstract][Full Text] [Related]
9. Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas.
Schneider S; Ferte T; Ducharme O; Dousset L; Prey S; Dutriaux C; Gerard E; Beylot-Barry M; Pham-Ledard A
J Cancer Res Clin Oncol; 2024 Mar; 150(3):133. PubMed ID: 38492114
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
11. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients-A Comparison between Different Immunomodulating Conditions.
Zavdy O; Coreanu T; Bar-On DY; Ritter A; Bachar G; Shpitzer T; Kurman N; Mansour M; Ad-El D; Rozovski U; Itchaki G; Sherman S; Azulay-Gitter L; Mizrachi A
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980651
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
14. Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
[TBL] [Abstract][Full Text] [Related]
15. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
17. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
18. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
Ogata D; Tsuchida T
Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
[TBL] [Abstract][Full Text] [Related]
19. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
Queirolo P; Cinquini M; Argenziano G; Bassetto F; Bossi P; Boutros A; Clemente C; de Giorgi V; Del Vecchio M; Patuzzo R; Pennachioli E; Peris K; Quaglino P; Reali A; Zalaudek I; Spagnolo F
ESMO Open; 2024 May; 9(5):103005. PubMed ID: 38688192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
